This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Nobler, M. S. Articles by Sackeim, H. A. Search for Related Content PubMed PubMed Citation Articles by Nobler, M. S. Articles by Sackeim, H. A. Pubmed/NCBI databases Medline Plus Health Information Seniors' Health Social Bookmarking                   What's this?

Cerebral Blood Flow and Metabolism in Late-Life Depression and Dementia

Gregory H. Pelton, MD

Harold A. Sackeim, PhD

Late-life depression (LLD) is characterized by abnormalities in cerebral blood flow (CBF) and cerebral metabolic rate (CMR) for glucose. Unlike younger adults with major depression, global cortical CBF and CMR reductions have been reported in LLD. Patients with LLD are also characterized by topographic abnormalities, most commonly involving selective prefrontal, superior temporal, and anterior parietal cortex. The fate of these abnormalities with response to antidepressant treatment is highly uncertain, and heterogeneous findings have been reported in younger samples with major depression. The limited data in LLD suggest that response to electroconvulsive therapy or anti depressant medications does not involve reversal of baseline abnormalities but rather accentuation of prefrontal deficits. At minimum, these paradoxical findings suggest that abnormalities in CBF and CMR may be persistent in LLD and a trait characteristic. Characteristic profiles of CBF and CMR abnormalities have also been demon strated in samples with Alzheimer's disease (AD) and other types of dementia. Functional imaging has shown sensitivity to disease severity and progression. Nonetheless, there is limited information regarding the sensitivity and specificity of the functional imaging modalities in the differential diagnosis of dementias. At present, the evi dence does not support the use of functional imaging in isolation as a diagnostic tool. Rather, these imaging modalities may be considered as an adjunct to careful clinical assessment, either to improve diagnosis in early cases or to assist in subtyping difficult cases. (J Geriatr Psychiatry Neurol 1999; 12:118-127).

Journal of Geriatric Psychiatry and Neurology, Vol. 12, No. 3, 118-127 (1999)
DOI: 10.1177/089198879901200305


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?